참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Metoclopramide | HCID 4168 | — |
| 반응물 | 4-amino-5-chloro-N-[2-(dimethylamino)ethyl]-2-methoxybenzamide | HCID 10378510 | — |
| 생성물 | HCID 14372582 | HCID 14372582 | 89% |
반응 단계
The general procedure of Preparation 1A was repeated except that the 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide utilized therein was replaced by 4-amino-5-chloro-N-[2-(dimethylamino)ethyl]-2-methoxybenzamide (prepared according to U.K. Pat. No. 1,793,771). The solvent (DMF) was removed in vacuo, and the residue treated with water and methylene chloride saturated with carbon dioxide, concentrated, and the crude product isolated in 89% yield by extraction with ethanol. A sample was chromatographed on a silica gel column usimg methylene chloride (97), methanol (3), ammonia (0.3) solvent system. The appropriate fractions were combined and concentrated in vacuo. The residue was crystallized from methanol to give the title compound as a colorless solid, mp. 163°-165°.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04820715 |
|---|
| 출처 데이터셋 | uspto-grants-1989_04 |
|---|
| ORD ID | ord-6127a8d94fc743ae828eae8a2d912673 |
|---|
| 출처 메모 | uspto-grants-1989_04 |
|---|